Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $8.7000 (1.52%) ($8.2700 - $9.1800) on Mon. Mar. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.95% (three month average) | RSI | 52 | Latest Price | $8.7000(1.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 4.8% a day on average for past five trading days. | Weekly Trend | FOLD declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(57%) XBI(53%) IWO(52%) IWM(48%) IWC(47%) | Factors Impacting FOLD price | FOLD will decline at least -3.475% in a week (0% probabilities). VIXM(-29%) VXX(-16%) TLT(-11%) UUP(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.475% (StdDev 6.95%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $8.74 | 5 Day Moving Average | $8.51(2.23%) | 10 Day Moving Average | $8.13(7.01%) | 20 Day Moving Average | $8.74(-0.46%) | To recent high | -22% | To recent low | 31.2% | Market Cap | $2.247b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |